The latest Investing Matters Podcast episode with multi-award-winning fund manager and international bestselling author Lee Freeman-Shor has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,831.00
Bid: 1,833.00
Ask: 1,835.00
Change: 8.00 (0.44%)
Spread: 2.00 (0.109%)
Open: 1,814.00
High: 1,845.00
Low: 1,814.00
Prev. Close: 1,823.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Markets nervous ahead of Jackson Hole

Wed, 29th Aug 2012 16:39

- Stocks look to Jackson Hole summit for a boost- Draghi hints at action ahead of ECB meeting- Glencore leads fallers on growing opposition to mergerGlobal stock markets were mostly trading in the red on Wednesday afternoon in spite an upwards revision to US economic growth as investors showed caution ahead of a meeting of central bankers this Friday.Investors are hoping that the Jackson Hole summit this week will see the US Federal Reserve hint at further stimulus measures like it has done in the past. However, in spite of an upwards revision to US gross domestic product (GDP) growth figures for the second quarter today - adjusted to an annual rate of 1.7% from 1.5% - US benchmarks slipped after the opening bell.Analyst Craig Erlam from Alpari said: "While [the data] in itself is unlikely to cause too much of a stir, the fact that the number has been revised higher since the last meeting is not going to work in the favour of those hoping the Fed loosen monetary policy next month."European Central Bank (ECB) President Mario Draghi is being forced to miss the Jackson Hole conference due to "a heavy workload", increasing speculation that he could be putting the finishes touches to plans for strong action ahead of an ECB meeting next week. Draghi hit back at German criticism of his bond-buying proposal today, sparking rumours that something big is on the horizon in Europe. The ECB "will always act within the limits of its mandate," Draghi said in German newspaper Die Zeit. "Yet it should be understood that fulfilling our mandate sometimes requires us to go beyond standard monetary policy tools."Alpari's Erlam said this afternoon: "I don't think there's any doubt any more than Draghi will announce their bond buying programme at the ECB press conference in September."In other news, German Chancellor Angela Merkel reiterated her opposition to the European Stability Mechanism being granted a banking licence, saying that the idea is "not compatible with the treaties". However, Italian Prime Minister Mario Monti argued that "modifications to the treaties can be asked for".FTSE 100: Glencore provides a drag on merger riskCommodities marketer and producer Glencore was leading the decline on the Footsie today, not only because it went ex-dividend today but as a result of reports that its proposed merger with mining giant Xstrata could be at risk. Xstrata shareholder Norges Bank Investment Management has raised its stake in the miner in the last few weeks, fuelling concerns that the Norwegian fund could join forces with Qatari Holdings to vote to block the merger.Miners on the whole were out of favour today as risk appetite waned. Rio Tinto, Kazakhmys, Anglo American and Vedanta Resources were registering moderate losses by the close. Copper producer Antofagasta was also lower despite beating earnings estimates in the first half as a decrease in copper prices was offset by higher levels of production. Outsourcing group Serco was higher after saying that it expects good growth in full-year organic revenues in 2012 despite a 2.1% fall in the first half. Utilities giant SSE was among the risers after Bank of America Merrill Lynch lifted its recommendation from 'neutral' to 'buy', explaining that the company's tariff increase announced last week has erased a downside risk to earnings. "The move underpins the profitability of the supply division and gives us greater confidence in the medium-term outlook for EPS and DPS progression," the broker said. Shares in Marks and Spencer were in red once again as takeover speculation continues to fade. The stock jumped on Friday after Bloomberg reported that private equity firm CVC was considering making an offer. However, analysts at Investec have said this morning that a successful bid is unlikely and the "bid spec bubble" is expected to burst. FTSE 250: RusPetro drops after swinging into the red West Siberia-focused oil and gas firm RusPetro was a heavy faller after reporting a pre-tax loss of $26.4m, compared with a profit of $0.6m in the first half of last year. Revenues, however, tripled as production ramps up. A host of second-tier stocks went ex-dividend today and were trading in the red, such as African Barrick Gold, Devro, Ferrexpo, Henderson, Hikma, Lancashire Holdings, Wood Group, Micro Focus, Rank Group and Stagecoach. FTSE 100 - RisersReed Elsevier (REL) 589.00p +1.90%Admiral Group (ADM) 1,196.00p +1.61%Babcock International Group (BAB) 914.00p +1.50%Whitbread (WTB) 2,133.00p +1.38%Compass Group (CPG) 717.00p +1.20%SSE (SSE) 1,372.00p +1.11%Aberdeen Asset Management (ADN) 277.50p +1.06%Bunzl (BNZL) 1,115.00p +1.00%Next (NXT) 3,625.00p +0.95%Sage Group (SGE) 298.70p +0.88%FTSE 100 - FallersGlencore International (GLEN) 368.50p -4.04%Rio Tinto (RIO) 2,773.50p -3.09%Weir Group (WEIR) 1,635.00p -2.79%Kazakhmys (KAZ) 617.00p -2.68%Anglo American (AAL) 1,816.00p -2.65%Vedanta Resources (VED) 889.00p -1.66%Lloyds Banking Group (LLOY) 33.49p -1.64%Xstrata (XTA) 924.10p -1.61%International Consolidated Airlines Group SA (CDI) (IAG) 142.70p -1.52%BHP Billiton (BLT) 1,904.00p -1.47%FTSE 250 - RisersCarpetright (CPR) 670.00p +4.69%Yule Catto & Co (YULC) 165.00p +4.43%Dialight (DIA) 1,140.00p +3.92%Homeserve (HSV) 220.60p +3.81%Ophir Energy (OPHR) 550.00p +3.58%Brewin Dolphin Holdings (BRW) 149.10p +3.11%SVG Capital (SVI) 279.10p +2.84%Afren (AFR) 128.20p +2.81%Cape (CIU) 192.60p +2.61%Euromoney Institutional Investor (ERM) 768.00p +2.26%FTSE 250 - FallersRuspetro (RPO) 125.50p -11.31%New World Resources A Shares (NWR) 276.00p -6.76%Bumi (BUMI) 321.30p -5.50%Ferrexpo (FXPO) 172.60p -4.11%Centamin (DI) (CEY) 76.15p -3.73%Talvivaara Mining Company (TALV) 130.00p -3.56%Lonmin (LMI) 608.00p -3.49%Rank Group (RNK) 135.70p -3.42%Henderson Group (HGG) 104.80p -2.69%Micro Focus International (MCRO) 545.00p -2.68%
More News
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.